Not Medicare Enrolled

Dr. Robin Lifton, M.D.

Hematology · Venice, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
901 TAMIAMI TRL S, Venice, FL 34285
9414843531
Registered in NPPES since 2005
NPI: 1437140068 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lifton from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lifton? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lifton

Dr. Robin Lifton is a hematology specialist in Venice, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lifton performed 321 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Lifton received a total of $4,463 from 51 pharmaceutical and/or device companies across 257 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lifton is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 321 Medicare services $4,463 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 73306 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
321
Medicare services
Bottom 13% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
175 $62 $197
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
116 $136 $556
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
30 $94 $285
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2022 ↗
$4,463
Total received (2018-2022)
Avg $893/year across 5 years
Bottom 39% in FL for hematology
51
Companies
257
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$824
2021
$406
2020
$485
2019
$1,363
2018
$1,386

Payments by company (2022)

BeiGene USA, Inc.
$149
Incyte Corporation
$94
Celgene Corporation
$79
PFIZER INC.
$64
Regeneron Healthcare Solutions, Inc.
$56
Daiichi Sankyo Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$44
ABBVIE INC.
$39
Amgen Inc.
$31
E.R. Squibb & Sons, L.L.C.
$25
Deciphera Pharmaceuticals Inc.
$23
JAZZ PHARMACEUTICALS INC.
$22
Gilead Sciences, Inc.
$22
EUSA Pharma (US) LLC
$21
Karyopharm Therapeutics Inc.
$21
EISAI INC.
$20
Janssen Pharmaceuticals, Inc
$20
Janssen Biotech, Inc.
$17
Kite Pharma, Inc.
$16
GENZYME CORPORATION
$14
Top 3 companies account for 39.1% of 2022 payments
All-time payments by company (2018-2022) ›
Novartis Pharmaceuticals Corporation
$401
Janssen Biotech, Inc.
$319
PFIZER INC.
$273
Genentech USA, Inc.
$264
Amgen Inc.
$247
Exelixis Inc.
$245
E.R. Squibb & Sons, L.L.C.
$207
Celgene Corporation
$175
Astellas Pharma US Inc
$162
Merck Sharp & Dohme Corporation
$155
BeiGene USA, Inc.
$149
AstraZeneca Pharmaceuticals LP
$145
GENZYME CORPORATION
$139
Bayer HealthCare Pharmaceuticals Inc.
$136
Incyte Corporation
$125
JAZZ PHARMACEUTICALS INC.
$121
SANOFI-AVENTIS U.S. LLC
$100
Regeneron Healthcare Solutions, Inc.
$88
Lilly USA, LLC
$85
Janssen Scientific Affairs, LLC
$78
Taiho Oncology, Inc.
$71
Daiichi Sankyo Inc.
$66
Janssen Pharmaceuticals, Inc
$65
Takeda Pharmaceuticals U.S.A., Inc.
$60
Gilead Sciences, Inc.
$45
EMD Serono, Inc.
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
ABBVIE INC.
$39
TerSera Therapeutics LLC
$32
Seagen Inc.
$31
Deciphera Pharmaceuticals Inc.
$23
Rigel Pharmaceuticals, Inc.
$23
Shire North American Group Inc
$21
EUSA Pharma (US) LLC
$21
Karyopharm Therapeutics Inc.
$21
Ipsen Biopharmaceuticals, Inc
$21
EISAI INC.
$20
AbbVie, Inc.
$19
AMAG Pharmaceuticals, Inc.
$18
Seattle Genetics, Inc.
$17
INSYS Therapeutics Inc
$16
Horizon Pharma plc
$16
Kite Pharma, Inc.
$16
Kyowa Kirin, Inc.
$15
ARRAY BIOPHARMA INC
$15
Partner Therapeutics, Inc.
$15
Aveo Pharmaceuticals, Inc.
$14
Teva Pharmaceuticals USA, Inc.
$13
GlaxoSmithKline, LLC.
$12
Heron Therapeutics, Inc.
$12
Clovis Oncology, Inc.
$11
Top 3 companies account for 22.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BENDEKA · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CYRAMZA · Cabometyx · DARZALEX · ELITEK · EMPLICITI · ENHERTU · ERLEADA · EVENITY · Erleada · FARESTON · FERAHEME · FOTIVDA · GAZYVA · GILOTRIF · HYQVIA · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRYSTEXXA · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · NINLARO · NUCALA · Neulasta · Nexavar · Nplate · ONUREG · OPDIVO · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · Perjeta · Pomalyst · QINLOCK · REBLOZYL · Rubraca · SANDOSTATIN LAR · SOMATULINE DEPOT · SUSTOL · SUTENT · SYNDROS · Stivarga · Sylvant · TASIGNA · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · ZEPZELCA · ZOLADEX · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology specialist in Venice?
Compare hematologists in the Venice area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists in nearby ZIP areas
21
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
SARASOTA MEMORIAL HOSPITAL - VENICE
4.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lifton is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lifton experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Lifton performed 175 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lifton receive payments from pharmaceutical companies?
Yes. Dr. Lifton received a total of $4,463 from 51 companies across 257 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lifton's costs compare to other hematologists in Venice?
Dr. Lifton's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Lifton) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →